Compare HOYA Corp. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 20.17%
- Company has very low debt and has enough cash to service the debt requirements
2
The company has declared Positive results for the last 4 consecutive quarters
3
With ROE of 25.00%, it has a attractive valuation with a 8.88 Price to Book Value
4
Majority shareholders : FIIs
Stock DNA
Pharmaceuticals & Biotechnology
JPY 8,386,018 Million (Large Cap)
36.00
NA
0.00%
-0.54
25.00%
8.22
Revenue and Profits:
Net Sales:
255,742 Million
(Quarterly Results - Jun 2026)
Net Profit:
65,835 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.46%
0%
-8.46%
6 Months
-3.67%
0%
-3.67%
1 Year
36.38%
0%
36.38%
2 Years
36.08%
0%
36.08%
3 Years
56.58%
0%
56.58%
4 Years
73.48%
0%
73.48%
5 Years
52.59%
0%
52.59%
HOYA Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.58%
EBIT Growth (5y)
12.00%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.83
Tax Ratio
23.30%
Dividend Payout Ratio
34.95%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
51.87%
ROE (avg)
20.17%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
8.88
EV to EBIT
30.36
EV to EBITDA
25.14
EV to Capital Employed
18.05
EV to Sales
8.98
PEG Ratio
1.35
Dividend Yield
NA
ROCE (Latest)
59.46%
ROE (Latest)
25.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 4 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
255,742.00
248,130.00
3.07%
Operating Profit (PBDIT) excl Other Income
98,146.00
90,103.00
8.93%
Interest
463.00
506.00
-8.50%
Exceptional Items
0.00
-2,322.00
100.00%
Consolidate Net Profit
65,835.00
53,912.00
22.12%
Operating Profit Margin (Excl OI)
321.20%
296.80%
2.44%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 3.07% vs 1.39% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 22.12% vs -40.87% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
947,749.00
866,032.00
9.44%
Operating Profit (PBDIT) excl Other Income
439,381.00
392,211.00
12.03%
Interest
1,764.00
1,326.00
33.03%
Exceptional Items
20,332.00
-4,733.00
529.58%
Consolidate Net Profit
251,451.00
201,750.00
24.63%
Operating Profit Margin (Excl OI)
402.20%
396.80%
0.54%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 9.44% vs 13.56% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 24.63% vs 10.51% in Mar 2025
About HOYA Corp. 
HOYA Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






